GlassScriptPhysician profile
Patrick Louie Calalang
NPI 1710029095
$4,525.10
in general payments reported to CMS, 2019-2025
11 companies · $348 in 2025
The $348 reported for 2025 was more than what 86% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $14.45 · 2021: $101 · 2022: $71.79 · 2023: $2,087 · 2024: $1,732 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,738 · Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,737.77 |
| Food and Beverage | $1,429.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuraray America INC. | $2,968.07 | 2023-2025 | |
| Bisco, INC. | $619.83 | 2023 | |
| Ivoclar Vivadent, INC. | $488.37 | 2021-2024 | |
| Align Technology, INC. | $121.95 | 2019-2022 | |
| Keystone Dental INC. | $103.64 | 2025 | |
| Straumann USA LLC | $75.00 | 2019 | |
| Gc America INC. | $53.11 | 2025 | Everstick, Equia |
| Dentsply Sirona INC | $37.32 | 2019 | |
| Abbvie INC. | $22.29 | 2022 | |
| Voco America INC. | $20.55 | 2025 | Grandio Blocs, Admira Fusion X-Tra, Meron Plus Qm |
| Philips North America LLC | $14.97 | 2025 | Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Calalang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.